Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -29.53%454.19M | -6.28%1.28B | 16.02%644.49M | 42.91%1.37B | 26.33%555.51M | -3.80%956.5M | -8.22%439.75M | 56.71%994.24M | 118.28%479.11M | 4.15%634.45M |
| Operating income | -29.53%454.19M | -6.28%1.28B | 16.02%644.49M | 42.91%1.37B | 26.33%555.51M | -3.80%956.5M | -8.22%439.75M | 56.71%994.24M | 118.28%479.11M | 4.15%634.45M |
| Cost of sales | 32.45%-427.5M | 3.48%-1.24B | -24.77%-632.89M | -45.32%-1.29B | -24.60%-507.26M | 2.49%-884.86M | 5.55%-407.1M | -60.03%-907.48M | -118.53%-431.02M | -6.14%-567.07M |
| Operating expenses | 32.45%-427.5M | 3.48%-1.24B | -24.77%-632.89M | -45.32%-1.29B | -24.60%-507.26M | 2.49%-884.86M | 5.55%-407.1M | -60.03%-907.48M | -118.53%-431.02M | -6.14%-567.07M |
| Gross profit | 130.19%26.69M | -50.64%40.03M | -75.97%11.6M | 13.18%81.09M | 47.80%48.25M | -17.42%71.64M | -32.11%32.64M | 28.75%86.76M | 116.04%48.09M | -10.06%67.38M |
| Administrative expenses | 18.64%-12.91M | -3.50%-35.91M | -10.08%-15.86M | 11.42%-34.69M | 7.76%-14.41M | -2.63%-39.16M | -12.68%-15.62M | -40.85%-38.16M | -13.88%-13.87M | -0.98%-27.09M |
| Special items of operating profit | -188.46%-8.12M | 234.40%15.3M | 191.62%9.18M | -248.39%-11.38M | -227.42%-10.02M | 790.94%7.67M | 735.71%7.86M | -95.03%861K | -92.05%941K | 789.98%17.33M |
| Operating profit | 15.33%5.67M | -44.53%19.42M | -79.37%4.91M | -12.80%35.01M | -4.29%23.82M | -18.82%40.15M | -29.23%24.89M | -14.16%49.46M | 60.40%35.16M | 15.15%57.62M |
| Financing cost | 58.59%-205K | 37.42%-811K | 25.23%-495K | 27.15%-1.3M | 12.43%-662K | -108.31%-1.78M | -153.69%-756K | -46.48%-854K | 22.60%-298K | 11.40%-583K |
| Earning before tax | 23.61%5.46M | -44.81%18.61M | -80.92%4.42M | -12.14%33.72M | -4.03%23.16M | -21.06%38.37M | -30.79%24.13M | -14.78%48.61M | 61.88%34.86M | 15.50%57.04M |
| Tax | -38.15%-2.86M | 29.25%-5.35M | 62.56%-2.07M | -35.57%-7.57M | -105.55%-5.52M | 24.34%-5.58M | 57.01%-2.69M | 19.50%-7.38M | -254.31%-6.25M | -2.59%-9.16M |
| After-tax profit from continuing operations | 10.81%2.6M | -49.31%13.26M | -86.67%2.35M | -20.26%26.15M | -17.76%17.63M | -20.47%32.79M | -25.06%21.44M | -13.88%41.23M | 44.71%28.61M | 18.35%47.87M |
| Earning after tax | 10.81%2.6M | -49.31%13.26M | -86.67%2.35M | -20.26%26.15M | -17.76%17.63M | -20.47%32.79M | -25.06%21.44M | -13.88%41.23M | 44.71%28.61M | 18.35%47.87M |
| Profit attributable to shareholders | 10.81%2.6M | -49.31%13.26M | -86.67%2.35M | -20.26%26.15M | -17.76%17.63M | -20.47%32.79M | -25.06%21.44M | -13.88%41.23M | 44.71%28.61M | 18.35%47.87M |
| Basic earnings per share | 13.33%0.0017 | -49.10%0.0085 | -86.73%0.0015 | -20.48%0.0167 | -17.52%0.0113 | -18.60%0.021 | -23.46%0.0137 | -23.21%0.0258 | 8.48%0.0179 | 6.33%0.0336 |
| Diluted earnings per share | 13.33%0.0017 | -49.70%0.0084 | -86.61%0.0015 | -20.10%0.0167 | -18.25%0.0112 | -18.99%0.0209 | -23.46%0.0137 | -23.21%0.0258 | 8.48%0.0179 | 6.33%0.0336 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.